AC-Selank-NH2

What it is?

AC-Selank-NH2 is a synthetic peptide positioned for anxiolytic and nootropic applications, commonly discussed for its effects on emotional stability and cognition without strong sedative signalling emphasis. It is used in protocols where stress resilience and learning efficiency are primary endpoints.

Dripfy Advantage

• BDNF-related modulation: Associated with modulation of brain-derived neurotrophic factor (BDNF) signalling, supporting neuroplasticity frameworks.
• Monoamine system influence: Positioned to influence serotonin and dopamine pathway dynamics relevant to mood regulation and cognitive function.
• Non-sedating anxiolytic profile: Frequently framed around anxiety reduction signalling without heavy sedation-related endpoints.
• Stress-adaptation support: Often positioned for improved stress response modulation and emotional resilience measures in high-pressure contexts.

Clinical Applications & Therapeutic Potential

• Anxiety reduction endpoints: Potential support for reduced anxiety markers with maintained functional alertness (protocol-dependent).
• Cognitive function outcomes: Potential improvements in clarity, focus, and cognitive efficiency markers.
• Stress resilience frameworks: Positioned for improved stress tolerance and emotional regulation endpoints.
• Learning and memory formation: Potential support for learning efficiency and memory consolidation markers via neurotrophic signalling pathways.

Composition & Formulation

• Peptide Content: 5 mg Selank
• Vehicle: Proprietary pH-balanced buffer solution
• Delivery System: Pre-filled, multi-dose, closed-system pen
• Total Volume: 3 mL
• Purity: ≥99% by HPLC/MS